Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421556![]() (3-[(4-Fluorophenyl)methyl]-N-(1-methylcyclopropyl)...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421539![]() (3-[(2,4-Dimethylthiazol-5-yl)methyl]-N-(1-methylcy...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421584![]() (3-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-flu...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421497![]() (US10508086, Example 87) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421498![]() (US10508086, Example 88) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421493![]() (US10508086, Example 83) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421492![]() (US10508086, Example 82) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421488![]() (US10508086, Example 79) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421482![]() (US10508086, Example 73) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371049![]() (US10239843, Example 156) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371026![]() (US10239843, Example 133) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371058![]() (US10239843, Example 165) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM205480![]() (PDD00017238 (5) | US10508086, Example 90) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371051![]() (US10239843, Example 158) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371056![]() (US10239843, Example 163) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371055![]() (US10239843, Example 162) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371054![]() (US10239843, Example 161) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371507![]() (1-Butyl-N-[1-(fluoromethyl)cyclopropyl]-3-[(1-meth...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371073![]() (US10239843, Example 180) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421626![]() (3-[5-(Difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-flu...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371518![]() (1-(2-Fluoroethyl)-N-[1-(fluoromethyl)cyclopropyl]-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371519![]() (N-[1-(Fluoromethyl)cyclopropyl]-1-[(1-methylpyrazo...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371520![]() (N-[1-(Fluoromethyl)cyclopropyl]-1-[(5-methyl-1,2,4...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421423![]() (N-(1-Methylcyclopropyl)-1-[2-(2-oxooxazolidin-3-yl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421528![]() (US10508086, Example 118) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421529![]() (US10508086, Example 119) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371506![]() (1-[(2,4-Dimethylthiazol-5-yl)methyl]-N-[1-(fluorom...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371504![]() (1-Ethyl-N-(1-methylcyclopropyl)-3-[(5-methyl-1,3,4...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371493![]() (1-Ethyl-N-[1-(fluoromethyl)cyclopropyl]-3-[(5-meth...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371470![]() (N-[1-(Fluoromethyl)cyclopropyl]-1-[(5-methylisoxaz...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371469![]() (N-[1-(Fluoromethyl)cyclopropyl]-1-(isothiazol-5-yl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371463![]() (N-[1-(Fluoromethyl)cyclopropyl]-3-[(1-methylpyrazo...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371376![]() (1-Chloro-N-(1-methylcyclopropyl)isoquinoline-7-sul...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371355![]() (1-[(2,4-Dimethylthiazol-5-yl)methyl]-N-[1-(fluorom...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371066![]() (US10239843, Example 173) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371204![]() (4-(Cyclopropanecarbonyl)-N-(1-methylcyclopropyl)-2...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371201![]() (US10239843, Example 308) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371191![]() (US10239843, Example 298) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371186![]() (US10239843, Example 293) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM370991![]() (US10239843, Example 98) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM370973![]() (US10239843, Example 80) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM370934![]() (4-Methyl-2-(methylamino)-N-(1-methylcyclopropyl)-3...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM370915![]() (1-(Cyclopropylmethyl)-4-methyl-N-(1-methylcyclopro...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM371514![]() (N-[1-(Fluoromethyl)cyclopropyl]-1-methyl-3-[(3-met...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10239843 (2019) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421623![]() (US10508086, Example 213) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421622![]() (3-[5-(Difluoromethyl)-1,3,4-oxadiazol-2-yl]-6-fluo...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421555![]() (3-(Cyclopropanecarbonyl)-1-[5-(difluoromethyl)-1,3...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421610![]() (3-[5-(Difluoromethyl)-1,3,4-oxadiazol-2-yl]-1-ethy...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421618![]() (3-[5-(Difluoromethyl)-1,3,4-thiadiazol-2-yl]-1-eth...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribose glycohydrolase ARH3 (Homo sapiens (Human)) | BDBM421621![]() (US10508086, Example 211) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 53 total ) | Next | Last >> |